<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">5975448</article-id>
    <article-id pub-id-type="publisher-id">2213</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-018-2213-3</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>JCDSA: a joint covariate detection tool for survival analysis on tumor expression profiles</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Yiming</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yanan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Yueming</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Shi</surname>
          <given-names>Yan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2272-6278</contrib-id>
        <name>
          <surname>Zhao</surname>
          <given-names>Xudong</given-names>
        </name>
        <address>
          <email>zhaoxudong@nefu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1789 9091</institution-id><institution-id institution-id-type="GRID">grid.412246.7</institution-id><institution>College of Information and Computer Engineering, Northeast Forestry University, </institution></institution-wrap>No.26 Hexing Road, Harbin, 150001 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1789 9091</institution-id><institution-id institution-id-type="GRID">grid.412246.7</institution-id><institution>College of Foreign Languages, Northeast Forestry University, </institution></institution-wrap>No.26 Hexing Road, Harbin, 150001 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>29</day>
      <month>5</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>29</day>
      <month>5</month>
      <year>2018</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2018</year>
    </pub-date>
    <volume>19</volume>
    <elocation-id>187</elocation-id>
    <history>
      <date date-type="received">
        <day>20</day>
        <month>8</month>
        <year>2017</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>5</month>
        <year>2018</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2018</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p>Survival analysis on tumor expression profiles has always been a key issue for subsequent biological experimental validation. It is crucial how to select features which closely correspond to survival time. Furthermore, it is important how to select features which best discriminate between low-risk and high-risk group of patients. Common features derived from the two aspects may provide variable candidates for prognosis of cancer.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>Based on the provided two-step feature selection strategy, we develop a joint covariate detection tool for survival analysis on tumor expression profiles. Significant features, which are not only consistent with survival time but also associated with the categories of patients with different survival risks, are chosen. Using the miRNA expression data (Level 3) of 548 patients with glioblastoma multiforme (GBM) as an example, miRNA candidates for prognosis of cancer are selected. The reliability of selected miRNAs using this tool is demonstrated by 100 simulations. Furthermore, It is discovered that significant covariates are not directly composed of individually significant variables.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p>Joint covariate detection provides a viewpoint for selecting variables which are not individually but jointly significant. Besides, it helps to select features which are not only consistent with survival time but also associated with prognosis risk. The software is available at <ext-link ext-link-type="uri" xlink:href="http://bio-nefu.com/resource/jcdsa">http://bio-nefu.com/resource/jcdsa</ext-link>.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Feature selection</kwd>
      <kwd>Expression profiles</kwd>
      <kwd>Survival analysis</kwd>
      <kwd>Prognosis</kwd>
      <kwd>Cancer</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Fundamental Research Funds for the Central Universities</institution>
        </funding-source>
        <award-id>2572018BH01</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Undergraduate Innovation Project</institution>
        </funding-source>
        <award-id>201610225050</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Specialized Personnel Start-up Grant(Also,National Construction Plan of World-class Universities and First-class Disciplines)</institution>
        </funding-source>
        <award-id>41113237</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2018</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p>Due to the limited effectiveness of current clinical diagnoses, expression profiles are utilized for informing variables, which are not only associated with the categories of patients with different survival risks but also consistent with survival time [<xref ref-type="bibr" rid="CR1">1</xref>]. Commonly, Cox proportional hazards regression analysis is used to seek relevant variables considering the continuity of the patients’ survival outcomes with right censoring [<xref ref-type="bibr" rid="CR2">2</xref>]. As to small sample data with high dimension, Cox proportional hazards regression has to be combined with methods using dimension reduction or shrinkage such as partial least squares [<xref ref-type="bibr" rid="CR3">3</xref>] and principal component analysis [<xref ref-type="bibr" rid="CR4">4</xref>]. However, these approaches only provide a combination of variables. Besides, tree-structured survival analysis [<xref ref-type="bibr" rid="CR5">5</xref>], random survival forests [<xref ref-type="bibr" rid="CR6">6</xref>] and that associated with hazards regression [<xref ref-type="bibr" rid="CR7">7</xref>] are proposed for selection of features associated with survival outcomes. Anyway, these top-down strategies provide so many variable candidates that the real features which may reveal the possible molecular cause of different survival risks are inevitably submerged.</p>
    <p>In contrast, univariable hazards regression analyses have been placed firmly in the mainstream. Bottom-up strategies with different constraints such as least-angle regression [<xref ref-type="bibr" rid="CR8">8</xref>] and sparse kernel [<xref ref-type="bibr" rid="CR9">9</xref>] are utilized for providing variables associated with survival time. To the best of our knowledge, we are the first to present joint covariate detection [<xref ref-type="bibr" rid="CR1">1</xref>] that combines significant variables consistent with survival time and associated with the categories of patients. Other than individually significant variables, we concentrate on bottom-up enumeration of feature tuples, each component of which is either individually significant or not. This thought is inspired by Integrative Hypothesis Testing [<xref ref-type="bibr" rid="CR10">10</xref>], which is used for selecting features differentially expressed between different groups of patients. Unlike Integrative Hypothesis Testing, joint covariate detection is faced with continuous survival time other than labels representing different categories of patients.</p>
    <p>In this paper, we further divide the provided feature selection into two steps, i.e., selection of variables associated with survival outcomes and further feature selection for discrimination between patients with different survival risks. In addition, we develop a joint covariate detection tool for survival analysis on tumor expression profiles (i.e. JCDSA), which helps to conveniently select significant features either on a cluster or a workstation, even on a personal computer. Matlab R2012b and Python 3 are utilized as the development platform. miRNA expression data (Level 3) of 548 patients with GBM downloaded from TCGA (<ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov">http://cancergenome.nih.gov</ext-link>) and the simulated data are considered to be the examples. Compared with the prevailing method named as random survival forests (i.e. RSF), JCDSA shows better experimental results, which demonstrates the effectiveness of our method.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <p>In order to elucidate joint covariate detection in brief, a schematic diagram is illustrated in Fig. <xref rid="Fig1" ref-type="fig">1</xref> (Notations: <bold>x</bold>
<sub>(<italic>i</italic>)</sub> and <bold>β</bold> denote the expression levels of sample <italic>i</italic> and the regression coefficients of the detected variables, respectively. The summation in the denominator is over all subjects in the risk set at ordered survival time <italic>t</italic><sub>(<italic>i</italic>)</sub>, denoted by <italic>R</italic>(<italic>t</italic><sub>(<italic>i</italic>)</sub>). <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$z_{k}^{0}$\end{document}</tex-math><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mi>z</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq1.gif"/></alternatives></inline-formula> denotes a null statistics by a random rearrangement of survival outcomes. The estimator of the expected number of deaths in high-risk group is denoted by <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\hat {e}_{1i}$\end{document}</tex-math><mml:math id="M4"><mml:msub><mml:mrow><mml:mi>ê</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq2.gif"/></alternatives></inline-formula>, expressed as <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\hat {e}_{1i}$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mrow><mml:mi>ê</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq3.gif"/></alternatives></inline-formula> = <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\frac {n_{1i}d_{i}}{n_{i}}$\end{document}</tex-math><mml:math id="M8"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq4.gif"/></alternatives></inline-formula>, where n <sub><italic>i</italic></sub> and d <sub><italic>i</italic></sub> represent the number at risk and of deaths at the observation of ordered survival time <italic>t</italic><sub>(<italic>i</italic>)</sub>, <italic>n</italic><sub>1<italic>i</italic></sub> denotes the number at risk in high-risk group. The estimator of the variance of <italic>d</italic><sub>1<italic>i</italic></sub> on the hypergeometric distribution is defined as <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\hat {v}_{1i}$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mrow><mml:mover accent="true"><mml:mrow><mml:mi>v</mml:mi></mml:mrow><mml:mo>^</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq5.gif"/></alternatives></inline-formula> = <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$\frac {n_{1i}n_{0i}d_{i}(n_{i} - d_{i})}{n_{i}^{2}(n_{i} - 1)}$\end{document}</tex-math><mml:math id="M12"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mrow><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>n</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq6.gif"/></alternatives></inline-formula>, where n <sub>0<italic>i</italic></sub> denotes the number at risk in low-risk group. Q<inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$_{r}^{0}$\end{document}</tex-math><mml:math id="M14"><mml:msubsup><mml:mrow/><mml:mrow><mml:mi>r</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq7.gif"/></alternatives></inline-formula> denotes a null statistics by a random rearrangement of survival outcomes). Input data is considered as expression profiles with survival time and censoring states of patients. Output data refers to selected features. Joint covariate detection corresponds to two-step feature selection, i.e., selection of features associated with survival outcomes and selection of features for discriminating between two risk groups.
<fig id="Fig1"><label>Fig. 1</label><caption><p>A schematic diagram to elucidate joint covariate detection</p></caption><graphic xlink:href="12859_2018_2213_Fig1_HTML" id="MO1"/></fig>
</p>
    <sec id="Sec3">
      <title>Features associated with survival outcomes</title>
      <p>We first consider to select features associated with survival time. A bottom-up enumeration on <italic>k</italic>-tuple with <italic>k</italic> variables is made. As to each <italic>k</italic>-tuple, Cox proportional hazards regression analysis [<xref ref-type="bibr" rid="CR2">2</xref>] is introduced. By making the maximum partial likelihood estimation on the partial likelihood function, we obtain <italic>k</italic> estimated regression coefficients on which Wald statistics are made. Furthermore, a permutation test is made on each Wald statistic. The <italic>k</italic>-tuple with each component corresponding to a significant <italic>p</italic> value is regarded as a candidate feature associated with survival outcomes. More details can be seen in [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
    </sec>
    <sec id="Sec4">
      <title>Features for discriminating between two risk groups</title>
      <p>We then intend to select features for discriminating between low-risk and high-risk group of patients, which conforms to doctors’ daily decision making process. As to each patient, a risk score which is the linear portion of the expression values using the Cox regression coefficients is calculated. A preassigned risk score is utilized as a cut-off value for stratification between high-risk and low-risk group of patients. Log-rank test is made. Furthermore, a permutation test is presented on each tuple, which has been selected to be associated with survival outcomes. The <italic>k</italic>-tuple with a significant <italic>p</italic> value is regarded as a candidate feature for discriminating between two risk groups. More details can be also seen in [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
    </sec>
    <sec id="Sec5">
      <title>Brief overview of the software</title>
      <p>Our software, which is implemented in Matlab R2012b or other later versions, can work on different computational platforms (e.g., a cluster, a workstation, even a personal computer). Therefore, it contains two parts, i.e., client and server. Selection of features associated with survival outcomes is accomplished by two Matlab m-files (i.e., ’/Client/S1_feature_selection.m’ and ’/Server/S1_feature_selection_on_server.m’). A further selection of features for stratification of patients is fulfilled by a Matlab m-file ’Client/S2_plot_draw.m’. If this program is implemented on a workstation or a personal computer, only the client part is needed. That is to say, users only need to concentrate on two GUIs (i.e., ’/Client/S1_feature_selection.m’ and ’Client/S2_plot_draw.m’) on the client part. Otherwise, the server part is also in demand. Data communications and environment configurations are actualized using Python 3. More details can be seen in the user’s guide on the website: <ext-link ext-link-type="uri" xlink:href="http://bio-nefu.com/resource/jcdsa">http://bio-nefu.com/resource/jcdsa</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec6" sec-type="results">
    <title>Results</title>
    <p>According to the presented two-step feature selection strategy, we first consider selecting features associated with survival outcomes. Figure <xref rid="Fig2" ref-type="fig">2</xref> illustrates this step. Cancer type can be selected or input by clicking the right side arrow if it is not supported in the type list. Other selections in the setting frame can be also made, details of which are listed in user’s guide. Before running at full speed, JCDSA estimates the finishing seconds which helps to make a further decision. After its completion, the result which records p value(s) of each <italic>k</italic>-tuple is stored in ’/Client/Data/S1’. Figure <xref rid="Fig3" ref-type="fig">3</xref> further illustrates the step of selecting features associated with survival outcomes (i.e., Step 2.1). By setting the threshold of the p value corresponding to permutation test on Wald statistic, features associated with survival outcomes are selected.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Selection of features associated with survival time</p></caption><graphic xlink:href="12859_2018_2213_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Selection of features for discriminating between two risk groups</p></caption><graphic xlink:href="12859_2018_2213_Fig3_HTML" id="MO3"/></fig>
</p>
    <p>Using the miRNA expression data (Level 3) of 548 patients with GBM as an example, individually significant miRNAs and significant miRNAs in pairs are listed in Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>, respectively. After making careful comparisons between Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>, we conclude that significant features in high dimension may not be composed of individually significant miRNAs. Taking the significant pair miR-10b and miR-222 as an example, miR-10b is not listed in Table <xref rid="Tab1" ref-type="table">1</xref>, which shows that it is not individually significant. This phenomenon reveals the advantage of using joint covariate detection.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Individually significant miRNAs using joint covariate detection (<italic>p</italic> &lt;=0.001)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left"><italic>β</italic>(Cox)</th><th align="left">Z(Cox)</th><th align="left">P(Cox)</th></tr></thead><tbody><tr><td align="left">hsa-miR-148a</td><td align="left">0.192</td><td align="left">4.607</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-17-3p</td><td align="left">-0.308</td><td align="left">-3.321</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-200a</td><td align="left">0.465</td><td align="left">3.563</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-20a</td><td align="left">-0.177</td><td align="left">-3.163</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-221</td><td align="left">0.284</td><td align="left">5.396</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-222</td><td align="left">0.246</td><td align="left">6.332</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">-0.468</td><td align="left">-3.498</td><td align="left">&lt;0.001</td></tr><tr><td align="left">hsa-miR-34a</td><td align="left">0.182</td><td align="left">4.287</td><td align="left">&lt;0.001</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Significant miRNAs in pairs using joint covariate detection (<italic>p</italic> &lt;0.001)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left">miRNA probe</th><th align="left"><italic>β</italic>(Cox)</th><th align="left"><italic>β</italic>(Cox)</th><th align="left">Z(Cox)</th><th align="left">Z(Cox)</th><th align="left">P(Cox)</th><th align="left">P(Cox)</th></tr></thead><tbody><tr><td align="left">hsa-miR-10b</td><td align="left">hsa-miR-222</td><td align="left">0.1412</td><td align="left">0.3061</td><td align="left">3.6472</td><td align="left">7.1789</td><td align="left">0.0004</td><td align="left">&lt;0.0001</td></tr><tr><td align="left">hsa-miR-140</td><td align="left">hsa-miR-148a</td><td align="left">-0.2450</td><td align="left">0.1956</td><td align="left">-3.3193</td><td align="left">4.7179</td><td align="left">0.0004</td><td align="left">&lt;0.0001</td></tr><tr><td align="left">hsa-miR-143</td><td align="left">hsa-miR-34a</td><td align="left">-0.2452</td><td align="left">0.2326</td><td align="left">-3.5230</td><td align="left">5.2069</td><td align="left">0.0004</td><td align="left">&lt;0.0001</td></tr><tr><td align="left">hsa-miR-182</td><td align="left">hsa-miR-204</td><td align="left">-0.1186</td><td align="left">0.1482</td><td align="left">-3.4971</td><td align="left">4.2846</td><td align="left">0.0004</td><td align="left">&lt;0.0001</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">hsa-miR-801</td><td align="left">-0.7523</td><td align="left">-0.2290</td><td align="left">-4.7672</td><td align="left">-4.0426</td><td align="left">&lt;0.0001</td><td align="left">0.0002</td></tr><tr><td align="left">hsa-miR-198</td><td align="left">hsa-miR-671</td><td align="left">0.6433</td><td align="left">-0.6435</td><td align="left">3.7746</td><td align="left">-3.9295</td><td align="left">0.0002</td><td align="left">0.0002</td></tr><tr><td align="left">hsa-miR-196a</td><td align="left">hsa-miR-20a</td><td align="left">0.2191</td><td align="left">-0.2120</td><td align="left">3.4284</td><td align="left">-3.6662</td><td align="left">0.0007</td><td align="left">0.0002</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">hsa-miR-452</td><td align="left">-0.7811</td><td align="left">-0.2872</td><td align="left">-4.8128</td><td align="left">-3.6202</td><td align="left">&lt;0.0001</td><td align="left">0.0003</td></tr><tr><td align="left">hsa-miR-196a</td><td align="left">hsa-miR-20b</td><td align="left">0.2159</td><td align="left">-0.2582</td><td align="left">3.3972</td><td align="left">-3.6163</td><td align="left">0.0008</td><td align="left">0.0003</td></tr><tr><td align="left">hsa-miR-196a</td><td align="left">hsa-miR-340</td><td align="left">0.2115</td><td align="left">-0.5325</td><td align="left">3.2889</td><td align="left">-3.8183</td><td align="left">0.0010</td><td align="left">0.0003</td></tr><tr><td align="left">hsa-miR-374</td><td align="left">hsa-miR-671</td><td align="left">-0.3845</td><td align="left">-0.2770</td><td align="left">-4.1883</td><td align="left">-3.5837</td><td align="left">0.0002</td><td align="left">0.0004</td></tr><tr><td align="left">hsa-miR-140</td><td align="left">hsa-miR-801</td><td align="left">-0.3620</td><td align="left">-0.2002</td><td align="left">-4.2702</td><td align="left">-3.6236</td><td align="left">&lt;0.0001</td><td align="left">0.0005</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">hsa-miR-671</td><td align="left">-0.7553</td><td align="left">-0.2512</td><td align="left">-4.6673</td><td align="left">-3.4952</td><td align="left">0.0002</td><td align="left">0.0005</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">hsa-miR-765</td><td align="left">-0.7652</td><td align="left">-0.2524</td><td align="left">-4.6791</td><td align="left">-3.4679</td><td align="left">&lt;0.0001</td><td align="left">0.0006</td></tr><tr><td align="left">hsa-miR-17-5p</td><td align="left">hsa-miR-196a</td><td align="left">-0.2635</td><td align="left">0.2226</td><td align="left">-3.8666</td><td align="left">3.4765</td><td align="left">&lt;0.0001</td><td align="left">0.0006</td></tr><tr><td align="left">hsa-miR-222</td><td align="left">hsa-miR-422b</td><td align="left">0.2911</td><td align="left">-0.3619</td><td align="left">7.0607</td><td align="left">-3.5045</td><td align="left">&lt;0.0001</td><td align="left">0.0007</td></tr><tr><td align="left">hsa-miR-140</td><td align="left">hsa-miR-671</td><td align="left">-0.3948</td><td align="left">-0.2333</td><td align="left">-4.2886</td><td align="left">-3.3077</td><td align="left">&lt;0.0001</td><td align="left">0.0007</td></tr><tr><td align="left">hsa-miR-340</td><td align="left">hsa-miR-370</td><td align="left">-0.7885</td><td align="left">-0.1201</td><td align="left">-4.6899</td><td align="left">-3.4386</td><td align="left">&lt;0.0001</td><td align="left">0.0007</td></tr><tr><td align="left">hsa-miR-374</td><td align="left">hsa-miR-663</td><td align="left">-0.3226</td><td align="left">-0.2551</td><td align="left">-3.9265</td><td align="left">-3.4033</td><td align="left">0.0002</td><td align="left">0.0007</td></tr><tr><td align="left">hsa-miR-190</td><td align="left">hsa-miR-374</td><td align="left">0.9479</td><td align="left">-0.2649</td><td align="left">3.4665</td><td align="left">-3.5370</td><td align="left">0.0004</td><td align="left">0.0007</td></tr><tr><td align="left">hsa-miR-148a</td><td align="left">hsa-miR-30e-3p</td><td align="left">0.2287</td><td align="left">-0.3551</td><td align="left">5.1831</td><td align="left">-3.1949</td><td align="left">&lt;0.0001</td><td align="left">0.0008</td></tr><tr><td align="left">hsa-miR-374</td><td align="left">hsa-miR-801</td><td align="left">-0.2932</td><td align="left">-0.1921</td><td align="left">-3.7141</td><td align="left">-3.4390</td><td align="left">0.0005</td><td align="left">0.0008</td></tr><tr><td align="left">hsa-miR-374</td><td align="left">hsa-miR-765</td><td align="left">-0.3481</td><td align="left">-0.2457</td><td align="left">-3.9480</td><td align="left">-3.2346</td><td align="left">0.0002</td><td align="left">0.0009</td></tr><tr><td align="left">hsa-miR-30e-3p</td><td align="left">hsa-miR-663</td><td align="left">-0.4564</td><td align="left">-0.2517</td><td align="left">-3.4388</td><td align="left">-3.2166</td><td align="left">0.0005</td><td align="left">0.0009</td></tr><tr><td align="left">hsa-miR-181c</td><td align="left">hsa-miR-675</td><td align="left">-0.2618</td><td align="left">-2.9279</td><td align="left">-3.6755</td><td align="left">-3.3646</td><td align="left">0.0003</td><td align="left">0.0010</td></tr><tr><td align="left">hsa-miR-200b</td><td align="left">hsa-miR-487b</td><td align="left">0.4543</td><td align="left">0.2424</td><td align="left">4.0048</td><td align="left">3.2972</td><td align="left">0.0007</td><td align="left">0.0010</td></tr></tbody></table></table-wrap>
</p>
    <p>Together, Figs. <xref rid="Fig3" ref-type="fig">3</xref>, <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref> illustrate the feature selection step for discriminating between two risk groups. In Fig. <xref rid="Fig3" ref-type="fig">3</xref>, after choosing the files that represent the original data and the result corresponding to significant features associated with survival time at Step 2.2, the software runs to Step 2.3 and Step 2.4.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Kaplan-Meier analysis</p></caption><graphic xlink:href="12859_2018_2213_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Risk score analysis</p></caption><graphic xlink:href="12859_2018_2213_Fig5_HTML" id="MO5"/></fig>
</p>
    <p>As shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>, Kaplan-Meier analysis with parameters derived from log-rank test and Harrell’s concordance index is made for further selection of features, which helps to discriminate between high-risk and low-risk group of patients. Meanwhile, the result of risk score analysis is illustrated in Fig. <xref rid="Fig5" ref-type="fig">5</xref>. Correspondingly, results which refer to significant features are stored in ’Client/Data/S2/S2_3’ and ’Client/Data/S2/S2_4’, respectively.</p>
    <p>In order to show the effectiveness of our method, we implemented the prevailing method named as random survival forests (i.e. RSF) on the miRNA expression data (Level 3) of 548 patients with GBM for comparison. 1000 binary survival trees were made, with each terminal node containing a minimum of <italic>d</italic><sub>0</sub>=10 unique deaths. We made 1000 permutations on each variable, and obtained the variable importance (VIMP) for each variable. The result is listed in Table <xref rid="Tab3" ref-type="table">3</xref>.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Significant miRNAs using random survival forests (VIMP score &gt;=0.001)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left">VIMP score</th></tr></thead><tbody><tr><td align="left">hsa-miR-222</td><td align="left">0.0103</td></tr><tr><td align="left">hsa-miR-148a</td><td align="left">0.0027</td></tr><tr><td align="left">hsa-miR-30d</td><td align="left">0.0012</td></tr><tr><td align="left">hsa-miR-27a</td><td align="left">0.0011</td></tr><tr><td align="left">hsa-miR-422b</td><td align="left">0.0011</td></tr></tbody></table></table-wrap>
</p>
    <p>After making careful comparisons between Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, we find that miR-10b is still unimportant, as it is not listed in Table <xref rid="Tab3" ref-type="table">3</xref>. This phenomenon reveals the advantage of using joint covariate detection other than RSF. In fact, the individually significant miR-222 keeps a <italic>p</italic>=0.0012 corresponding to log-rank test with 10000 rounds of permutation. As to significant pair (i.e., miR-222 and miR-10b), it keeps a <italic>p</italic>=0.0002 which corresponds to log-rank test with 10000 rounds of permutation. As to miR-10b, it keeps a <italic>p</italic>=0.285, which is individually insignificant.</p>
    <p>We simulated data under 40 independent dimensions, from which we assigned two to be significant. That is, the survival time <italic>S</italic> is defined as <italic>S</italic>=<italic>e</italic><italic>x</italic><italic>p</italic>(−<bold>X</bold><italic>β</italic>+<italic>ε</italic>), where <bold>X</bold> is the simulated gene expression matrix and <italic>β</italic>=[0.9,0.1,0.001,...,0.001]<sub>40</sub> denotes the coefficient parameter. <italic>ε</italic>∼<italic>N</italic>(0,2). The sample size <italic>n</italic> is 50. The censoring states are generated, and yield 10 percent censoring for the simulated data.</p>
    <p>The experimental results on simulated data are listed in Tables <xref rid="Tab4" ref-type="table">4</xref>, <xref rid="Tab5" ref-type="table">5</xref> and <xref rid="Tab6" ref-type="table">6</xref>, respectively. The significant pair closely associated with simulated survival outcomes are selected out, as shown in Table <xref rid="Tab5" ref-type="table">5</xref>. In contrast, miRNA-alternative 2 which is in absence in Table <xref rid="Tab4" ref-type="table">4</xref> shows insignificant (<italic>p</italic>=0.939), and illustrates less important in Table <xref rid="Tab6" ref-type="table">6</xref>. These results demonstrate the effectiveness of our method. The simulated data and full tables corresponding to Tables <xref rid="Tab4" ref-type="table">4</xref>, <xref rid="Tab5" ref-type="table">5</xref> and <xref rid="Tab6" ref-type="table">6</xref> can be downloaded on the website: <ext-link ext-link-type="uri" xlink:href="http://bio-nefu.com/resource/jcdsa">http://bio-nefu.com/resource/jcdsa</ext-link>.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Individually significant miRNAs using joint covariate detection on the simulated data (<italic>p</italic> &lt;=0.05)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left"><italic>β</italic>(Cox)</th><th align="left">Z(Cox)</th><th align="left">P(Cox)</th></tr></thead><tbody><tr><td align="left">miRNA-alternative 1</td><td align="left">4.739</td><td align="left">5.929</td><td align="left">&lt;0.001</td></tr><tr><td align="left">miRNA-null 33</td><td align="left">-0.3583</td><td align="left">-1.9486</td><td align="left">0.023</td></tr></tbody></table></table-wrap><table-wrap id="Tab5"><label>Table 5</label><caption><p>Significant miRNAs in pairs using joint covariate detection on the simulated data (<italic>p</italic> &lt;=0.001)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left">miRNA probe</th><th align="left"><italic>β</italic>(Cox)</th><th align="left"><italic>β</italic>(Cox)</th><th align="left">Z(Cox)</th><th align="left">Z(Cox)</th><th align="left">P(Cox)</th><th align="left">P(Cox)</th></tr></thead><tbody><tr><td align="left">miRNA-alternative 1</td><td align="left">miRNA-alternative 2</td><td align="left">7.6975</td><td align="left">0.8455</td><td align="left">5.1236</td><td align="left">3.6895</td><td align="left">&lt;0.001</td><td align="left">&lt;0.001</td></tr></tbody></table></table-wrap><table-wrap id="Tab6"><label>Table 6</label><caption><p>Significant miRNAs using random survival forests on the simulated data (VIMP score &gt;=0.001)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">miRNA probe</th><th align="left">VIMP score</th></tr></thead><tbody><tr><td align="left">miRNA-alternative 1</td><td align="left">0.1887</td></tr><tr><td align="left">miRNA-null 32</td><td align="left">0.0016</td></tr><tr><td align="left">miRNA-alternative 2</td><td align="left">0.0013</td></tr><tr><td align="left">miRNA-null 10</td><td align="left">0.0013</td></tr></tbody></table></table-wrap>
</p>
    <p>In order to show that selected variables are improbable false positive or false negative ones, we repeated the simulations above for 100 times with an enlarged sample size (<italic>n</italic>=500). The experimental results are illustrated in Fig. <xref rid="Fig6" ref-type="fig">6</xref>. Figure <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">a</xref> denotes the p values (<italic>p</italic>&lt;1<italic>e</italic>−3) of the significant pair through 100 times of simulation. However, miRNA-alternative 2 individually shows less important, as illustrated in Fig. <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">b</xref>. Comparisons between Fig. <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">a</xref> and <xref rid="Fig6" ref-type="fig">b</xref> indicate that the significant features are probably not composed of individually significant uni-variables. Figure <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">c</xref> and <xref rid="Fig6" ref-type="fig">d</xref> report the number of positive pairs and individuals through 100 times of simulation, respectively. No false negative results are discovered. In Fig. <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">c</xref>, the maximum number of false positive pair is three, which indicates a small probability of false positive pair 0.0038 (i.e., <inline-formula id="IEq8"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$3/C_{40}^{2}$\end{document}</tex-math><mml:math id="M16"><mml:mn>3</mml:mn><mml:mo>/</mml:mo><mml:msubsup><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mn>40</mml:mn></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2018_2213_Article_IEq8.gif"/></alternatives></inline-formula>). As to Fig. <xref rid="Fig6" ref-type="fig">6</xref><xref rid="Fig6" ref-type="fig">d</xref>, the maximum number of false positive individual is also three; yet, the probability of false positive individual is 0.075 (i.e., 3/40).
<fig id="Fig6"><label>Fig. 6</label><caption><p>Simulation results. <bold>a</bold> p values of the significant pair through 100 times of simulation. <bold>b</bold> p values of the significant individual through 100 times of simulation. <bold>c</bold> The number of positive pairs through 100 times of simulation. <bold>d</bold> The number of positive individuals through 100 times of simulation</p></caption><graphic xlink:href="12859_2018_2213_Fig6_HTML" id="MO6"/></fig>
</p>
  </sec>
  <sec id="Sec7" sec-type="discussion">
    <title>Discussion</title>
    <p>There are several states needed to be discussed. First, it is the significant multi-variable other than combinations of individually significant uni-variables that contributes to selection of features not only consistent with survival outcomes but also associated with stratification of patients under different survival risks. This fact has been demonstrated by our experimental results in this paper. Second, components of each significant multi-variable may keep a low correlation. This phenomenon has been discovered when experiments on the simulated data were made. Further evidence is still needed. Third, the correction for multiple hypothesis testing is absent, considering the computational cost of calculating FDR, q value, the adjusted p values, etc. on each pair or each high-dimension tuple of variables. However, simulations are made, which demonstrate the effectiveness of our method.</p>
  </sec>
  <sec id="Sec8" sec-type="conclusion">
    <title>Conclusion</title>
    <p>Our joint covariate detection for survival analysis provides a new viewpoint for selecting variable candidates which are not individually but jointly significant. Following a two-step variable selection strategy, we propose a software (i.e., JCDSA) in order to help users to select features which are not only consistent with survival time but also associated with prognosis risk. JCDSA can be adapted for many categories of cancer. Users can easily operate it and conveniently obtain the experimental results for subsequent biological experimental validation.</p>
  </sec>
  <sec id="Sec9">
    <title>Availability and requirements</title>
    <p><bold>Project name</bold>: JCDSA <bold>Project home page</bold>: <ext-link ext-link-type="uri" xlink:href="http://bio-nefu.com/resource/jcdsa">http://bio-nefu.com/resource/jcdsa</ext-link><bold>Operating system(s)</bold>: Linux, Windows <bold>Programming language</bold>: Matlab (≥R2012b), Python (≥ 3.0) <bold>License</bold>: GPL (≥2) <bold>Any restrictions to use by non-academics</bold>: none</p>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>GUI</term>
        <def>
          <p>Graphical user interface</p>
        </def>
      </def-item>
      <def-item>
        <term>GBM</term>
        <def>
          <p>Glioblastoma multiforme</p>
        </def>
      </def-item>
      <def-item>
        <term>JCDSA</term>
        <def>
          <p>Joint covariate detection for survival analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>TCGA</term>
        <def>
          <p>The Cancer Genome Atlas</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
    <sec id="d29e2106">
      <title>Funding</title>
      <p>This work has been supported by the financial support of Fundamental Research Funds for the Central Universities (No. 2572018BH01), National Undergraduate Innovation Project (No. 201610225050) and Specialized Personnel Start-up Grant (Also National Construction Plan of World-class Universities and First-class Disciplines, No. 41113237). The funding body of Fundamental Research Funds for the Central Universities played an important role in the design of the study, collection, analysis and interpretation of data and in writing the manuscript.</p>
    </sec>
    <sec id="d29e2111">
      <title>Availability of data and materials</title>
      <p>The dataset analysed during the current study is available in the TCGA repository, <ext-link ext-link-type="uri" xlink:href="http://cancergenome.nih.gov">http://cancergenome.nih.gov</ext-link>. The simulated data can be downloaded on <ext-link ext-link-type="uri" xlink:href="http://bio-nefu.com/resource/jsdca">http://bio-nefu.com/resource/jsdca</ext-link>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>XDZ conceived the general project and supervised it. YMW<sup>1</sup>, YNL, YMW<sup>3</sup> and XDZ were the principal developers. YMW<sup>1</sup> has rewritten almost all the front-end codes and has majorly made the revision on the manuscript. YNL has made the supplementary experiments on new simulated data, which helps to illustrate the effectiveness of JCDSA on avoiding false positives. YS tested the software and made the improvement. XDZ wrote the underlying source code and the original manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="COI-statement">
    <sec id="d29e2141">
      <title>Ethics approval and consent to participate</title>
      <p>Not applicable.</p>
    </sec>
    <sec id="d29e2146">
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec id="d29e2151">
      <title>Publisher’s Note</title>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </sec>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>CQ</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>XD</given-names>
          </name>
        </person-group>
        <article-title>Joint covariate detection on expression profiles for selecting prognostic mirnas in glioblastoma</article-title>
        <source>Biomed Res Int</source>
        <year>2017</year>
        <volume>2</volume>
        <fpage>1</fpage>
        <lpage>10</lpage>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cox</surname>
            <given-names>DR</given-names>
          </name>
        </person-group>
        <article-title>Regression models and life tables (with discussion)</article-title>
        <source>J R Stat Soc Series B</source>
        <year>1972</year>
        <volume>34</volume>
        <fpage>187</fpage>
        <lpage>220</lpage>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Gui</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Partial cox regression analysis for high-dimensional microarray gene expression data</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <fpage>208</fpage>
        <lpage>15</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bth900</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Dimension reduction methods for microarrays with application to censored survival data</article-title>
        <source>Bioinformatics</source>
        <year>2004</year>
        <volume>20</volume>
        <fpage>3406</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bth415</pub-id>
        <?supplied-pmid 15256406?>
        <pub-id pub-id-type="pmid">15256406</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wallace</surname>
            <given-names>ML</given-names>
          </name>
        </person-group>
        <article-title>Time-dependent tree-structured survival analysis with unbiased variable selection through permutation tests</article-title>
        <source>Stat Med</source>
        <year>2013</year>
        <volume>33</volume>
        <fpage>4790</fpage>
        <lpage>804</lpage>
        <pub-id pub-id-type="doi">10.1002/sim.6261</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ishwaran</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kogalur</surname>
            <given-names>UB</given-names>
          </name>
          <name>
            <surname>Blackstone</surname>
            <given-names>EH</given-names>
          </name>
          <name>
            <surname>Lauer</surname>
            <given-names>MS</given-names>
          </name>
        </person-group>
        <article-title>Random survival forests</article-title>
        <source>Ann Appl Stat</source>
        <year>2008</year>
        <volume>2</volume>
        <fpage>841</fpage>
        <lpage>60</lpage>
        <pub-id pub-id-type="doi">10.1214/08-AOAS169</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kawaguchi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Yajima</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tsuchiya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Homma</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Natsumeda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fujii</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kakuma</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yamanaka</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Gene expression signature-based prognostic risk score in patients with glioblastoma</article-title>
        <source>Cancer Sci</source>
        <year>2013</year>
        <volume>104</volume>
        <fpage>1205</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1111/cas.12214</pub-id>
        <?supplied-pmid 23745793?>
        <pub-id pub-id-type="pmid">23745793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gui</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>HZ</given-names>
          </name>
        </person-group>
        <article-title>Penalized cox regression analysis in the high-dimensional and low-sample size settings, with applications to microarray gene expression data</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <fpage>3001</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bti422</pub-id>
        <?supplied-pmid 15814556?>
        <pub-id pub-id-type="pmid">15814556</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Evers</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Messow</surname>
            <given-names>CM</given-names>
          </name>
        </person-group>
        <article-title>Sparse kernel methods for high-dimensional survival data</article-title>
        <source>Bioinformatics</source>
        <year>2008</year>
        <volume>24</volume>
        <fpage>1632</fpage>
        <lpage>8</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btn253</pub-id>
        <?supplied-pmid 18515276?>
        <pub-id pub-id-type="pmid">18515276</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Bi-linear matrix-variate analyses, integrative hypothesis tests, and case-control studies</article-title>
        <source>Appl Inform</source>
        <year>2015</year>
        <volume>2</volume>
        <fpage>1</fpage>
        <lpage>39</lpage>
        <pub-id pub-id-type="doi">10.1186/s40535-014-0004-0</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
